However, the mechanisms by which IL-33/ST2 is involved in the disease are more complex and heterogeneous than those already reported in allergic airway inflammation (like in asthma), meaning that its role in COPD is rather defined by the context and progression of the disease which definitely deserves more research. This evidence concerns the gene IL33 and asthma.